RMB Capital Management LLC Has $12.46 Million Stake in CME Group Inc (NASDAQ:CME)

RMB Capital Management LLC boosted its position in shares of CME Group Inc (NASDAQ:CME) by 0.2% during the second quarter, HoldingsChannel reports. The institutional investor owned 64,199 shares of the financial services provider’s stock after purchasing an additional 121 shares during the period. RMB Capital Management LLC’s holdings in CME Group were worth $12,461,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Close Asset Management Ltd acquired a new stake in shares of CME Group in the 1st quarter valued at approximately $34,000. Advantage Investment Management LLC boosted its stake in shares of CME Group by 119.0% in the 2nd quarter. Advantage Investment Management LLC now owns 184 shares of the financial services provider’s stock valued at $36,000 after purchasing an additional 100 shares in the last quarter. Westside Investment Management Inc. acquired a new stake in shares of CME Group in the 2nd quarter valued at approximately $38,000. Permanens Capital L.P. acquired a new stake in shares of CME Group in the 1st quarter valued at approximately $41,000. Finally, Motco boosted its stake in shares of CME Group by 55.8% in the 2nd quarter. Motco now owns 268 shares of the financial services provider’s stock valued at $52,000 after purchasing an additional 96 shares in the last quarter. Hedge funds and other institutional investors own 84.99% of the company’s stock.

NASDAQ CME traded up $0.10 during trading hours on Friday, reaching $205.48. The company’s stock had a trading volume of 66,765 shares, compared to its average volume of 1,077,492. The firm has a fifty day simple moving average of $211.18 and a 200-day simple moving average of $191.03. The stock has a market cap of $73.56 billion, a P/E ratio of 30.13, a P/E/G ratio of 4.57 and a beta of 0.19. CME Group Inc has a 52 week low of $161.05 and a 52 week high of $224.91. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.05 and a quick ratio of 1.05.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.75 by $0.01. The business had revenue of $1.27 billion during the quarter, compared to analyst estimates of $1.27 billion. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The firm’s quarterly revenue was up 20.1% on a year-over-year basis. During the same quarter last year, the business earned $1.74 EPS. On average, research analysts expect that CME Group Inc will post 6.69 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Tuesday, September 10th will be issued a $0.75 dividend. The ex-dividend date of this dividend is Monday, September 9th. This represents a $3.00 dividend on an annualized basis and a yield of 1.46%. CME Group’s dividend payout ratio (DPR) is presently 43.99%.

In other CME Group news, insider Sean Tully sold 7,200 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $223.13, for a total transaction of $1,606,536.00. Following the completion of the transaction, the insider now owns 19,923 shares in the company, valued at approximately $4,445,418.99. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Terrence A. Duffy sold 35,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $200.15, for a total transaction of $7,005,250.00. Following the transaction, the chief executive officer now owns 79,057 shares of the company’s stock, valued at approximately $15,823,258.55. The disclosure for this sale can be found here. In the last quarter, insiders sold 59,626 shares of company stock valued at $12,255,934. 1.20% of the stock is owned by company insiders.

A number of equities research analysts have recently weighed in on CME shares. BidaskClub downgraded shares of CME Group from a “buy” rating to a “hold” rating in a research note on Thursday. Barclays raised their price target on shares of CME Group from $191.00 to $197.00 and gave the company an “overweight” rating in a research note on Thursday, May 23rd. Zacks Investment Research downgraded shares of CME Group from a “hold” rating to a “sell” rating and set a $158.00 price target on the stock. in a research note on Monday, May 27th. Deutsche Bank raised their price target on shares of CME Group from $224.00 to $240.00 and gave the company a “buy” rating in a research note on Friday, August 9th. Finally, UBS Group raised their price target on shares of CME Group from $191.00 to $214.00 and gave the company a “neutral” rating in a research note on Thursday, September 5th. Three analysts have rated the stock with a sell rating, six have assigned a hold rating and seven have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $196.85.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Read More: What are the benefits of investing in REITs?

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.